NFKB1 and hepatocellular carcinoma: Previous work has documented that hyper-expression of COMMD7 activates NF-κB p65 in HCC, so we proceeded to investigate whether the biological function of COMMD7 in AML is achieved through activation of the NF-κB pathway 32.